Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Total Liabilities (2020 - 2025)

iHuman has reported Total Liabilities over the past 6 years, most recently at $52.6 million for Q4 2025.

  • Quarterly Total Liabilities fell 17.62% to $52.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.6 million through Dec 2025, down 17.62% year-over-year, with the annual reading at $53.4 million for FY2025, 15.1% down from the prior year.
  • Total Liabilities was $52.6 million for Q4 2025 at iHuman, down from $63.9 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $79.3 million in Q4 2022 and troughed at $52.6 million in Q4 2025.
  • The 5-year median for Total Liabilities is $68.4 million (2023), against an average of $68.2 million.
  • Biggest five-year swings in Total Liabilities: rose 26.27% in 2021 and later decreased 17.62% in 2025.
  • Tracing IH's Total Liabilities over 5 years: stood at $77.0 million in 2021, then grew by 2.93% to $79.3 million in 2022, then dropped by 13.7% to $68.4 million in 2023, then dropped by 6.66% to $63.9 million in 2024, then dropped by 17.62% to $52.6 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $52.6 million, $63.9 million, and $68.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.